Yeast species of the genus Candida are the most prevalent fungi recovered from the oral cavity. The reported rate of oral Candida among healthy individuals varies from 35 to 80%, depending on the population studied and the detection methods. 1, 2 Debilitation of an individual can resulted in the occurrence of oral Candida infection (oral candidiasis). It is an opportunistic disease and the incidence of oral candidiasis has increased as a result of the escalation of human immunodeficiency virus infection and the more widespread use of immunosuppressive chemotherapy. 3 In addition, higher incidences of Candida isolation from oral conditions not previously associated with Candida infection have been reported. 3 These include high incidences of Candida in the mouth of patients with lichen planus, burning mouth syndrome, dry mouth, and leukoplakia. 3, 4, 5 The significance of Candida in these patients is uncertain, but it has been attracting increasing interest.
The conventional detection method for oral Candida is a culture of oral samples (i.e., smear, swab, or imprint specimen; whole saliva; and oral rinse solution). However, many studies have pointed out the low positivity of cultures. 3, 6, 7 Clinicians and researchers require a reliable and sensitive method to detect oral Candida. In recent years, numerous DNA-based methods have been reported to detect oral Candida species. 3, 7 However, they are still laborious and costly, and have technical problems such as the risk of contamination. The methods for DNA extraction and detection should be both standardized and simplified to introduce a molecular diagnostic method for the routine examination of oral samples.
Various laboratory tests based on the detection of Candida-specific antibodies, antigens, or metabolites have been developed for serological diagnosis of candidemia. Candida mannan antigen detection is a reliable and sensitive method for serological diagnosis of systemic candidiasis, and an assay kit is commercially available. [8] [9] [10] The Unimedi Candida is a microplate enzyme immunoassay employing affinity-purified polyclonal antibodies against Candida albicans mannan. The detection method is generally prepared with C. albicans antigen, but it allows the detection of antigens against other Candida species. It was reported that the Unimedi Candida test was more sensitive and specific than other commercially available mannan antigen detection kits using a monoclonal antibody against Candida albicans mannan. 9, 11 Studies have yet to be performed that employed mannan antigen detection as a detection tool for presence of Candida in the oral cavity. Therefore, the purpose of this study was to test the hypothesis that a mannan antigen detection enzyme-linked immunosorbent assay (ELISA) kit can be used in the detection of oral Candida. In this study, the performance of a commercially available mannan antigen detection kit (Unimedi Candida) for the detection of Candida in oral rinse solutions was assessed.
Material and Methods
This study was independently reviewed and approved by the University ethical board. The experiments were undertaken with the understanding and written consent of each subject and according to ethical principles, including the World Medical Association Declaration of Helsinki (version, 2002) .
Forty-eight oral rinse solutions were available for the study. Ten samples were obtained from 10 healthy volunteers (4 women and 6 men, with a mean age of 27.9 years). Thirty-eight samples were obtained from 25 patients (20 women and 5 men, with a mean age of 71.1 years) who attended our clinic complaining of burning mouth and were clinically suspected of being colonized/infected with Candida. In 13 patients, repeated samplings were carried out before and after treatment with antifungal agents. The oral rinse solution was collected by rinsing the mouth with 10 ml of sterile phosphate-buffered saline which was held in the mouth for 1 minute prior to collection in a sterile container. A portion (10 µl) of the oral rinse solution was cultured on plates of CHROMagar Candida, which were incubated for 48 hours at 37˚C for isolation of multiple yeast species. Yeast identity was confirmed with the API 20C AUX system (bioMérieux, Marcy l'Etoile, France). The number of Candida colonies was calculated and reported in five categories: 0, 1-9, 10-99, 100-999, and more than 1,000 cfu/culture.
Mannan antigen was measured using a commercial sandwich ELISA, Unimedi Candida (Unitika, Amagasaki, Japan). The test was performed according to the manufacturer's instructions. Briefly, the oral rinse solution (150 µl) was mixed with 150 µl of treatment solution (including 20 nmol/L of sodium dihydrogen phosphate), boiled for 4 min, and then centrifuged at 10,000 G for 10 minutes. Supernatant (100 µl) was added to antibody-coated microtiter plate wells. After incubation at room temperature for 2 hours, the plates were washed thoroughly and 100 µl alkaline phosphatase-conjugated antibodies were added to the wells. After further incubation at room temperature for 1 hour, the plates were washed. The reaction was revealed by incubation with 100 µl substrate solution for 20 min at room temperature. After the addition of 100 µl stopping solution to the wells, optical density was read at 490-500 nm on a microplate reader. Each experiment included positive and negative controls as well as a calibration curve, which was made with a pool of normal human serum supplemented with known concentrations of mannan. Mannan concentrations greater than 0.05 U/ml (serological cut-off value) were considered a positive result, according to the manufacturer's recommendations.
Results
Candida was detected by culture in 20 (52.6%) of 38 oral rinse solutions from the clinical patients and 2 (20%) of the 10 oral rinse solutions from healthy volunteers. Of the 22 culture-positive samples, C. albicans was evident in 19 (86.4%) samples, C. glabrata in 6 (27.3%) samples, and C. parapsilosis in one (4.5%) sample (Table 1) . Although Candida albicans was most frequently encountered, only non-albicans Candida was detected in 3 (13.6%) samples. More than one Candida species was detected in 4 (18.2%) samples (Table 1) .
The result of the mannan assay revealed that 31 (81.6%) of 38 clinical samples and 3 (30%) of 10 healthy volunteer samples were positive for Candida. The agreement between Candida culture and mannan antigen detection of Candida is shown in Tables 1,  2 and 3 . Using culture as a gold standard, the overall sensitivity and specificity of the mannan antigen detection was 90.9% and 46.2%, respectively. Fourteen out of 26 culture-negative samples (53.8%) were judged as positive by mannan antigen detection, while only two out of 22 culture-positive samples (9.1%) were judged as negative by Candida antigen detection. Of these two samples, one was culture positive for only C. glabrata (Table 1 ). The other was culture positive for C. albicans (Table 1) and showed a borderline result in the mannan assay (mannan concentration of 0.04 U/ml, Table 3 ).
The relationship between mannan concentration in the immunoassay and the number of Candida colonies in culture are also shown in Table 3 and there was a statistically significant correlation between them (R 2 =0.488; Spearman rank correlation test, p<0.01). The results of assessment of mannan concentrations before and after treatment with antifungal agent are shown in Figure 1 . Eleven of 13 patients showed a significant reduction in mannnan concentration between before and after antifungal treatment (median of 0.4 U/ml before treatment vs. median of 0.11 U/ml after treatment, Wilcoxon signed-ranks test, p<0.05). In the mycological assessment by culture, eight of 13 patients had Candida-positive cultures before the treatment. Of these eight patients, six showed negative culture after the antifungal treatment.
Discussion
The Unimedi Candida assay uses affinity-purified polyclonal antibodies against Candida albicans mannan. The detection method is generally prepared with C. albicans antigen, but allows for the detection of antigens against other Candida species. The method employs enzymatic cycling that improves the sensitivity of the immunoassay. In the detection of serum mannan antigens in patients with candidemia, a high sensitivity of 69% and specificity of 89% was reported. 9 It was also reported that the Unimedi Candida showed high sensitivity for the detection of mannanaemia with C. albicans, C. tropicalis, C. guilliermondii, and C. tropicalis, while low sensitivity for that with C. glabrata, C. parapsilosis, and C. krusei. 9, 11 The Unimedi Candida is generally prepared for serum samples and, to the best of our knowledge, this is the first application of manna antigen detection in an oral rinse solution.
In this study, the result of the mannan assay revealed that 31 (81.6%) of 38 clinical samples and 3 (30%) of 10 healthy volunteer samples were positive for Candida. White et al. used real-time polymerase chain reaction (PCR) to detect Candida in concentrated oral rinse cultures and reported that 97 (67%) of the 145 clinical samples and 17 (38%) of the 48 healthy control samples were positive for Candida. 3 Liguori et al. used a multiplex PCR assay directly for oral rinse solutions and reported that 64 (82.1%) of 78 samples from symptomatic patients were positive for Candida. 7 Our results are compatible with their results. These results suggest that the mannan antigen detection in oral rinse solution might be a sensitive assay for the detection of oral Candida, possibly being as sensitive as DNA-based methods. In addition, the results of assessment of mannan concentrations before and after treatment with antifungal agent showed a significant decrease of mannan concentrations following treatment. This result also strongly supports the sensitivity of the mannan antigen detection for oral Candida.
In this study, the results of mannan detection achieved 90.9% agreement with those of the culture-positive samples. The mannan detection assay showed a low false-negative rate (2 samples, 9.1%). Of the two false-negative results, one showed only C. glabrata, with a mannan concentration of 0.02 U/ml, that was under the serological cut-off value of > 0.05 U/ml. In the results of this study, the Unimedi Candida showed high sensitivity for C. albicans (93.8%, 15/16), while lower specificity for C. glabrata. The difference in Candida species probably related to the false-negative result. The other false-negative result showed C. albicans, with a mannan concentration of 0.04 U/ml, which was the lowest concentration in the culture-positive samples for C. albicans and was a borderline concentration. As shown in this study, there was a positive correlation between mannan concentrations in the immunoassay and the number of Candida colonies. If all samples with a mannan concentration equal to or more than 0.02 U/ml were judged as positive for Candida, no false-negative results would have been reported. In the mannan assay of this study, an ELISA standard curve using pooled serum provided by the manufacturer was used. Thus, it is possible that the significance of the standard ELISA curve and the cut-off value should be reconsidered in the detection of Candida in oral rinse solutions with respect to the cut-offs used for serum.
On the other hand, mannan immunoassay detected 14 mannan-positive samples among the 26 culture-negative samples, possibly highlighting the higher sensitivity of mannan antigen detection than the culture of oral rinse solutions. Considering the mechanism of detecting Candida by manman immunoassay and the possibility of detecting nonviable cells, the higher sensitivity of the mannan antigen detection compared to culture is understandable. This is also consistent with other studies where PCRs have been found to be more sensitive than conventional culture methods. 3, 6, 7, 8 In conclusion, the results of this study suggest that mannan antigen detection might be a possible and sensitive technique for the detection of oral Candida. Further studies which discuss the agreement between Candida detection by mannan antigen and that by DNA-based methods are mandatory. In addition, because the mannan antigen detection kit (the Unimedi Candida) employed in the study is generally prepared for serum samples, studies that evaluate optimal conditions of the ELISA-based assay for oral rinse solutions and determine the detection limit of mannan antigen detection for oral Candida in oral rinse solution are important to be performed. 
